Search results
FDA: Cue Health COVID tests may return false positive, negative results, so throw them away
Naples Daily News via Yahoo News· 2 days agoAnyone experiencing problems with the test, including suspected false results, can report it to the...
FDA advises against using Cue Health COVID-19 tests, sends warning letter
MedTech Dive via Yahoo Finance· 3 days agoHowever, COVID-19 sales collapsed before Cue could step up other revenue drivers, leading to a...
Endoscopist Quality Matters After Positive Stool Test
Medscape· 3 days agoHigher endoscopist polyp detection rates were significantly associated with fewer negative...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time via AOL· 6 hours agoThese issues went unexplained for years; he recalls one doctor shaking him by the shoulders,...
Right-wing media figures are declaring bird flu the next “plandemic”
Media Matters· 7 hours agoAs livestock in several states have tested positive for a strain of bird flu, right-wing media...
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 2 days agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...
Celebrity News | Entertainment News | TMZ.com
TMZ· 6 days agoArticles - August, 2020 Celebrity Quarantine Birthdays -- Celebrate In Place! Rod Woodson Names Mean Joe Greene Greatest Steeler Of All-Time, Sorry, Terry! Aussie Rules Star Nic Naitanui Warns NBA, Bubble Life Takes
ROSEN, NATIONAL TRIAL COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before...
FOX 16 Little Rock· 6 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024, both dates inclusive ...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Benzinga· 8 hours agoLOS ANGELES, May 16, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of
New synthetic biomarker technology differentiates between prior Zika and dengue infections
Medical Xpress· 3 days agoA newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune...